271 related articles for article (PubMed ID: 12107440)
1. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain.
Balmer D; Arredondo J; Samaco RC; LaSalle JM
Hum Genet; 2002 Jun; 110(6):545-52. PubMed ID: 12107440
[TBL] [Abstract][Full Text] [Related]
2. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
Wan M; Zhao K; Lee SS; Francke U
Hum Mol Genet; 2001 May; 10(10):1085-92. PubMed ID: 11331619
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
Samaco RC; Hogart A; LaSalle JM
Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
[TBL] [Abstract][Full Text] [Related]
4. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
LaSalle JM; Goldstine J; Balmer D; Greco CM
Hum Mol Genet; 2001 Aug; 10(17):1729-40. PubMed ID: 11532982
[TBL] [Abstract][Full Text] [Related]
5. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D; Simcox T; Samaco RC; LaSalle JM
Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
[TBL] [Abstract][Full Text] [Related]
6. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
Amir RE; Van den Veyver IB; Wan M; Tran CQ; Francke U; Zoghbi HY
Nat Genet; 1999 Oct; 23(2):185-8. PubMed ID: 10508514
[TBL] [Abstract][Full Text] [Related]
7. Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation.
Kaufmann WE; Jarrar MH; Wang JS; Lee YJ; Reddy S; Bibat G; Naidu S
Brain Dev; 2005 Aug; 27(5):331-9. PubMed ID: 16023547
[TBL] [Abstract][Full Text] [Related]
8. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.
Ballestar E; Ropero S; Alaminos M; Armstrong J; Setien F; Agrelo R; Fraga MF; Herranz M; Avila S; Pineda M; Monros E; Esteller M
Hum Genet; 2005 Jan; 116(1-2):91-104. PubMed ID: 15549394
[TBL] [Abstract][Full Text] [Related]
9. Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples.
Thatcher KN; Peddada S; Yasui DH; Lasalle JM
Hum Mol Genet; 2005 Mar; 14(6):785-97. PubMed ID: 15689352
[TBL] [Abstract][Full Text] [Related]
10. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression.
Makedonski K; Abuhatzira L; Kaufman Y; Razin A; Shemer R
Hum Mol Genet; 2005 Apr; 14(8):1049-58. PubMed ID: 15757975
[TBL] [Abstract][Full Text] [Related]
11. Rett syndrome: the complex nature of a monogenic disease.
Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
Chen RZ; Akbarian S; Tudor M; Jaenisch R
Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
[TBL] [Abstract][Full Text] [Related]
13. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
Amir RE; Zoghbi HY
Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222
[TBL] [Abstract][Full Text] [Related]
14. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
[TBL] [Abstract][Full Text] [Related]
15. Ube3a expression is not altered in Mecp2 mutant mice.
Jordan C; Francke U
Hum Mol Genet; 2006 Jul; 15(14):2210-5. PubMed ID: 16754645
[TBL] [Abstract][Full Text] [Related]
16. Association by guilt: identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome.
Bapat S; Galande S
Bioessays; 2005 Jul; 27(7):676-80. PubMed ID: 15954098
[TBL] [Abstract][Full Text] [Related]
17. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
Horike S; Cai S; Miyano M; Cheng JF; Kohwi-Shigematsu T
Nat Genet; 2005 Jan; 37(1):31-40. PubMed ID: 15608638
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients.
Delgado IJ; Kim DS; Thatcher KN; LaSalle JM; Van den Veyver IB
BMC Med Genet; 2006 Jul; 7():61. PubMed ID: 16859563
[TBL] [Abstract][Full Text] [Related]
19. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots.
Wan M; Lee SS; Zhang X; Houwink-Manville I; Song HR; Amir RE; Budden S; Naidu S; Pereira JL; Lo IF; Zoghbi HY; Schanen NC; Francke U
Am J Hum Genet; 1999 Dec; 65(6):1520-9. PubMed ID: 10577905
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of MECP2 mutations in Rett syndrome.
Bienvenu T; Villard L; De Roux N; Bourdon V; Fontes M; Beldjord C; Tardieu M; Jonveaux P; Chelly J;
Genet Test; 2002; 6(1):1-6. PubMed ID: 12180070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
